DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ORE1001
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORE1001
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRS-343
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PRS-343
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IT-139
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
IT-139
×
Maximum Phase:
1
First Approval:
None
UNII:
7OSJ9KS483
Molecule Type:
Small molecule
Molecular Formula:
C14H12Cl4N4NaRu
Molecular Weight:
502.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZD-4190
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor 2 inhibitor
ZD-4190
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H17BrClFN6O2
Molecular Weight:
495.74
AlogP:
3.95
PSA:
86.98
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BAY-1082439
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-alpha subunit inhibitor
BAY-1082439
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06688992
1
Unknown
Investigational
Unknown
Unknown
Melanoma
Unknown
PF-06688992
×
Maximum Phase:
1
First Approval:
None
UNII:
X6L6R3CFT8
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
H3B-6527
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
H3B-6527
×
Maximum Phase:
1
First Approval:
None
UNII:
4HTE364XIK
Molecule Type:
Small molecule
Molecular Formula:
C29H34Cl2N8O4
Molecular Weight:
629.55
AlogP:
5.48
PSA:
124.19
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MVT-1075
1
Unknown
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Unknown
MVT-1075
×
Maximum Phase:
1
First Approval:
None
UNII:
473BOU89F3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1059615
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase class I inhibitor
GSK-1059615
×
Maximum Phase:
1
First Approval:
None
UNII:
07YMO87363
Molecule Type:
Small molecule
Molecular Formula:
C18H11N3O2S
Molecular Weight:
333.37
AlogP:
3.62
PSA:
71.95
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PENETRATIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PENETRATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A2AQZ20TEK
Molecule Type:
Protein
Molecular Formula:
C104H169N35O19S
Molecular Weight:
2245.79
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARC1905
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ARC1905
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-2780301
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasm Metastasis
Ribosomal protein S6 kinase (P70S6K) inhibitor
LY-2780301
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AUTOLOGOUS HUMAN UMBILICAL CORD BLOOD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AUTOLOGOUS HUMAN UMBILICAL CORD BLOOD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACY-241
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ACY-241
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-779788
1
Small molecule
Investigational
Unknown
Unknown
Atherosclerosis
LXR-beta agonist
BMS-779788
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2'-FUCOSYLLACTOSE
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative; Crohn Disease
Unknown
2'-FUCOSYLLACTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
XO2533XO8R
Molecule Type:
Small molecule
Molecular Formula:
C18H32O15
Molecular Weight:
488.44
AlogP:
-6.7
PSA:
256.29
HBD:
10.0
HBA:
#RotB:
10.0
Source:
BUTANE
1
Small molecule
Investigational
Unknown
Unknown
Essential Hypertension
Unknown
BUTANE
×
Maximum Phase:
1
First Approval:
None
UNII:
6LV4FOR43R
Molecule Type:
Small molecule
Molecular Formula:
C4H10
Molecular Weight:
58.12
AlogP:
1.81
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
TANIBORBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections; Pyelonephritis
Unknown
TANIBORBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
8IGQ156Z07
Molecule Type:
Small molecule
Molecular Formula:
C19H28BN3O5
Molecular Weight:
389.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LY-2874455
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor inhibitor
LY-2874455
×
Maximum Phase:
1
First Approval:
None
UNII:
E9M363811V
Molecule Type:
Small molecule
Molecular Formula:
C21H19Cl2N5O2
Molecular Weight:
444.32
AlogP:
4.76
PSA:
88.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AN-2718
1
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis
Unknown
AN-2718
×
Maximum Phase:
1
First Approval:
None
UNII:
810U6C2DGG
Molecule Type:
Small molecule
Molecular Formula:
C7H6BClO2
Molecular Weight:
168.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-817378
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
BMS-817378
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SIBROTUZUMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Fibroblast activation protein alpha binding agent
SIBROTUZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
552U6E1NIW
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CTT-1057
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
CTT-1057
×
Maximum Phase:
1
First Approval:
None
UNII:
QMH3V8VSPB
Molecule Type:
Small molecule
Molecular Formula:
C28H40FN4O14P
Molecular Weight:
706.61
AlogP:
0.84
PSA:
295.06
HBD:
9.0
HBA:
#RotB:
25.0
Source:
PIDACMERAN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PIDACMERAN
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGS62P1
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AGS62P1
×
Maximum Phase:
1
First Approval:
None
UNII:
37I4D4Q7S2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIGULIXOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TIGULIXOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
TAK-164
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-164
×
Maximum Phase:
1
First Approval:
None
UNII:
QCA97P3GSS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
L-KYNURENINE
1
Small molecule
Investigational
Unknown
Unknown
Headache
Unknown
L-KYNURENINE
×
Maximum Phase:
1
First Approval:
None
UNII:
02JW4J5R44
Molecule Type:
Small molecule
Molecular Formula:
C10H12N2O3
Molecular Weight:
208.22
AlogP:
0.25
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CYC-065
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
Unknown
CYC-065
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
117
118
119
120
121
122
123
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA